During titration, it is not recommended to increase by more than 2.5 mg every 4 weeks to avoid side effects
Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J
The peptide's chemical identification is CAS 137525-51-0, and it was first isolated and characterized in the 1990s from the protective secretions of the stomach lining
Clinical Trial Results: Tirzepatide (All Forms Mounjaro, Zepbound, Compounded): Because the active ingredient is identical, effectiveness is the same: SURMOUNT-1 Trial Results (72 weeks): 15 mg dose: 22.5% average body weight loss 10 mg dose: 21.4% average body weight loss 5 mg dose: 15.0% average body weight loss 96% of patients lost at least 5% of body weight 89% of patients lost at least 10% of body weight 63% of patients lost at least 20% of body weight Real-World Effectiveness: Compounded tirzepatide produces identical results to brand-name because its the same molecule at the same doses
If it happens at all, its likely only an issue during a creatine loading phase
Each injection should be at least one inch away from the previous one
.png)
